Cystic Fibrosis in Egypt
Pediatric Pulmonology · 2026-11 · 61 (11)
DOI: 10.1002/ppul.71899 ↗At a glance
Multizentrische Studie in Pediatric Pulmonology, published online on 2026-11-07. Written by Samya Z Nasr and 15 co-authors. Institution: Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA. Major MEDLINE topics: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. 22 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cystic Fibrosis Foundation, Middle East CF Association grants support.
Abstract (original language)
Background
Published data on cystic fibrosis (CF) among Egyptian people with cystic fibrosis (pwCF) are limited, and most previous reports have been from single centers. This study describes the demographic, clinical, and CFTR variant characteristics of a large multicenter cohort of Egyptian pwCF.
Methods
We conducted a multicenter retrospective descriptive cohort study including pwCF treated at seven Egyptian university children's hospitals from 2020 through 2024. Eligible participants had clinical features consistent with CF and positive sweat chloride testing. Demographic, clinical, sweat chloride, and genetic testing data were collected from medical records. All participants underwent limited CFTR variant testing; participants with one or no identified variants were eligible for additional CFTR sequencing when available.
Results
A total of 475 Egyptian pwCF were included. Participants were recruited from Cairo University, Ain Shams University, Zagazig University, Mansoura University, Tanta University, Alexandria University, and Assiut University. Among the cohort, 175 participants had two identified CFTR variants, 32 had one identified variant, and 268 had no variant identified on available testing. F508del was the most frequent variant, followed by N1303K. Nine novel CFTR variants were identified.
Conclusion
This multicenter retrospective cohort study represents one of the largest reported cohorts of Egyptian pwCF. The findings highlight the genetic heterogeneity of CF in Egypt and support the development of an Egyptian CFTR variant panel, expanded access to comprehensive genetic testing, and broader implementation of newborn screening.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Ain Shams University, Cairo, Egypt.
- Cairo University, Cairo, Egypt.
- Zagazig University, Zagazig, Egypt.
- Assiut University, Assiut, Egypt.
- Mansoura University, Mansoura, Egypt.
ORCID profiles: Samya Z Nasr, Salma Fleifil, Terez B Kamel, Heba A Ali, Deiaaeldin Tamer, Rehab Elmeazawy, Nader Fasseeh, Milan Macek
Funding
- Cystic Fibrosis Foundation
- Middle East CF Association grants support
Cite
APA
Nasr, S. Z., Fleifil, S., Fouda, E., Kamel, T. B., Ali, H. A., Naguib, M. L., ElAttar, M. M., Elbasha, N. R. M., Taha, O., Sarhan, D. T., Tamer, D., Regal, M. E. E., Elmeazawy, R., Fasseeh, N., Libik, M. M., & Macek, M. (2026). Cystic Fibrosis in Egypt. Pediatric Pulmonology, 61(11). https://doi.org/10.1002/ppul.71899
Vancouver
Nasr SZ, Fleifil S, Fouda E, Kamel TB, Ali HA, Naguib ML, et al. Cystic Fibrosis in Egypt. Pediatric Pulmonology. 2026;61(11). doi:10.1002/ppul.71899
BibTeX
@article{Nasr2026,
author = {Nasr, Samya Z and Fleifil, Salma and Fouda, Eman and Kamel, Terez B and Ali, Heba A and Naguib, Maggie Louis and ElAttar, Mona Mohsen and Elbasha, Noussa Ragab Mohamed and Taha, Osama and Sarhan, Dina T and Tamer, Deiaaeldin and Regal, Mohammed Ezz El and Elmeazawy, Rehab and Fasseeh, Nader and Libik, Mgr Malgorzata and Macek, Milan},
title = {Cystic Fibrosis in Egypt},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {11},
doi = {10.1002/ppul.71899}
}
EUVIMED